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Background: Failure of compensatory angiogenesis may contribute to decompensation of cardiac hypertrophy. We previously showed that a 
myocyte-restricted p300 transgene drives adaptive cardiac hypertrophy that leads to heart failure between 7-9 months of age.
Methods and Results: Here we show that the adaptive phase of p300-driven hypertrophy is accompanied by robust angiogenic gene expression 
and blood vessel growth. However, a steep fall in angiogenic transcripts occurs after 5 months together with a corresponding rise in expression of 
miR-17-3p which shares with miR-20a a seed sequence that is predicted to bind in the 3’UTRs of HIF1a and VEGFA as well as in p300 itself. In 
p300tg myocardium in vivo, p300 bound to a novel enhancer directly upstream of miR-20a; this site was predominantly bound by HDAC9 in wt 
littermates. Lentiviral-mediated overexpression of miR-20a suppressed expression of basal and hypoxia-induced HIF-1A VEGFA, alpha-actinin, and 
p300 in cardiac progenitor cells (CPCs), and reduced F-actin content and cytoskeletal organization in both cardiac myocytes and CPCs, consistent 
with p300 loss. Overexpression of miR-20a in CPCs enforced an angiogenic transcription profile nearly identical to that of p300tg myocardium 
at 9 months, together with significantly reduced proliferation rates. In contrast, CPCs with miR-20a knockdown exhibited increased endothelial 
differentiation in co-culture with cardiomyocytes. Consistent with its targeting of p300, neonatal delivery of a lentivirus driving miR-20a, but not a 
scrambled sequence significantly blunted the development of heart failure in p300 tg hearts.
Conclusions: These findings indicate that p300 induces expression of both angiogenic genes and anti-angiogenic microRNAs, including miR-20a, 
as part of a negative feedback loop that reduces p300 levels during hypertrophy and leads to a secondary loss of compensatory angiogenesis. Our 
findings suggest that introducing miR-20a in the early stages of cardiac hypertrophy can prevent heart failure, by titration of p300.
